Target intelligence / Profile preview

CD8+ Cytotoxic T Lymphocyte (CTL)

Target: CTL
Molecular classification: Lymphocyte, T cell

Overview

CD8+ cytotoxic T lymphocytes (CTLs) are a specialized subset of T cells critical for immune defense against intracellular pathogens, such as viruses and some bacteria, as well as for tumor surveillance. They recognize antigenic peptides presented by MHC I molecules on target cells and eliminate target cells through the release of cytolytic molecules (perforin, granzymes), Fas/Fas ligand pathway, and cytokine secretion (TNF-alpha, IFN-gamma). Activated CTLs can differentiate into memory CD8+ T-cells, enabling rapid response upon re-exposure to previously encountered antigens.

Other names: Cytotoxic T cellKiller T cellCD8+ T cellTc cell

Mechanism of action

N/A

Biological functions

Immune responseCell-mediated cytotoxicityAntiviral immunityAntitumor immunityCytokine productionMemory formation

Disease associations

Viral infectionCancerAutoimmunityTransplant rejection

Safety considerations

Cytokine release syndrome (CRS)Immune-related adverse events (irAEs)Graft-versus-host disease (GVHD)Autoimmunity

Interacting drugs

Immunosuppressants (e.g., Cyclosporine, Tacrolimus)

3 more in the full profile.

Biomarkers

CD8+ T cell countExpression of activation markers (e.g., CD69, CD25)Cytokine production (e.g., IFN-gamma, TNF-alpha)Expression of inhibitory receptors (e.g., PD-1, LAG3)

Beyond the preview

Go deeper on CD8+ Cytotoxic T Lymphocyte (CTL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD8+ Cytotoxic T Lymphocyte (CTL).

Explore the full profile